COMPANY
Providence Medical Technology
Timeline
- Trial start Not phased (device or behavioral study): Evaluation of the Safety and Effectiveness of the CORUS™ Posterior Cervical Stabilization System 3D (PCSS 3D) for the Treatment of 2-level Cervical Degenerative Disease source ↗
- FDA FDA 510(k) clearance: CORUS Navigation System-GN — K261665, Jun 18, 2026. Applicant at approval: Providence Medical Technology, Inc. source ↗
- FDA FDA 510(k) clearance: CORUS Posterior Cervical Stabilization System 3D (CORUS PCSS 3D) — K253676, May 14, 2026. Applicant at approval: Providence Medical Technology, Inc. source ↗
- Trial start Not phased (device or behavioral study): Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes source ↗
- FDA FDA 510(k) clearance: CORUS-LX Implant — K253190, Nov 20, 2025. Applicant at approval: Providence Medical Technology, Inc. source ↗
- FDA FDA 510(k) clearance: CORUS Navigation System-GX — K251060, Jul 30, 2025. Applicant at approval: Providence Medical Technology, Inc. source ↗
- FDA FDA 510(k) clearance: CAVUX Facet Fixation System (CAVUX FFS) and CORUS-LX Implant — K251885, Jul 10, 2025. Applicant at approval: Providence Medical Technology, Inc. source ↗
- Trial start Not phased (device or behavioral study): Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD source ↗
- Trial start Not phased (device or behavioral study): Evaluation of Cervical Fusion With DTRAX® Cervical Cage With DTRAX Bone Screw source ↗
- Trial start Not phased (device or behavioral study): Evaluation of DTRAX Graft in Patients With Cervical Degenerative Disc Disease source ↗
Upcoming milestones
- Jul 1, 2028 (ESTIMATED) · Not phased · Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes · NCT07222787
- Dec 1, 2029 (ESTIMATED) · Not phased · Evaluation of the Safety and Effectiveness of the CORUS™ Posterior Cervical Stabilization System 3D (PCSS 3D) for the Treatment of 2-level Cervical Degenerative Disease · NCT07721493
Clinical trials (lead sponsor) 5
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07222787 | Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes | Not phased (device or behavioral study) | Recruiting | Dec 1, 2025 | Jul 1, 2028 (estimated) |
| NCT07721493 | Evaluation of the Safety and Effectiveness of the CORUS™ Posterior Cervical Stabilization System 3D (PCSS 3D) for the Treatment of 2-level Cervical Degenerative Disease | Not phased (device or behavioral study) | Not yet recruiting | Jun 30, 2026 | Dec 1, 2029 (estimated) |
| NCT04229017 | Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD | Not phased (device or behavioral study) | Active, not recruiting | Mar 18, 2020 | Jul 22, 2024 (actual) |
| NCT01616719 | Evaluation of DTRAX Graft in Patients With Cervical Degenerative Disc Disease | Not phased (device or behavioral study) | Withdrawn | 2012-05 | 2014-02 (estimated) |
| NCT02694250 | Evaluation of Cervical Fusion With DTRAX® Cervical Cage With DTRAX Bone Screw | Not phased (device or behavioral study) | Withdrawn | 2015-11 | 2016-09 (actual) |
FDA records (last 2 years)
- FDA 510(k) clearance: CORUS Navigation System-GN — K261665, Jun 18, 2026. Applicant at approval: Providence Medical Technology, Inc. source ↗
- FDA 510(k) clearance: CORUS Posterior Cervical Stabilization System 3D (CORUS PCSS 3D) — K253676, May 14, 2026. Applicant at approval: Providence Medical Technology, Inc. source ↗
- FDA 510(k) clearance: CORUS-LX Implant — K253190, Nov 20, 2025. Applicant at approval: Providence Medical Technology, Inc. source ↗
- FDA 510(k) clearance: CORUS Navigation System-GX — K251060, Jul 30, 2025. Applicant at approval: Providence Medical Technology, Inc. source ↗
- FDA 510(k) clearance: CAVUX Facet Fixation System (CAVUX FFS) and CORUS-LX Implant — K251885, Jul 10, 2025. Applicant at approval: Providence Medical Technology, Inc. source ↗